Timothy Perren: Consultant Cancer Specialist, Leeds
Consultant Cancer Specialist, Leeds: Dr Timothy Perren
A highly experienced consultant oncologist specialising in the non-surgical treatment of breast and gynaecological cancers, based in Leeds.
Dr Timothy Perren is Consultant Medical Oncologist at Leeds Teaching Hospitals NHS Trust and Honorary Senior Lecturer at the University of Leeds. He provides private cancer treatment both for newly diagnosed patients and those with recurrent or metastatic conditions at Spire Leeds Hospital and at Nova Healthcare, a specialist unit based within St James's Institute of Oncology, Leeds.
St James's Institute of Oncology
Expert treatment of breast and gynaecological cancers in Leeds
Based at St James's Institute of Oncology, one of the
largest and most technically advanced cancer centres in Europe, Dr
Perren specialises in the treatment of breast and gynaecological cancers
using chemotherapy, hormonal therapy and the latest targeted therapies, such as Avastin and Herceptin. He works closely with the same team of surgeons,
radiologists and pathologists in both his NHS and private practice, providing an integrated and tailored
approach to treatment and always putting the patient, their family and
needs at the heart of any decision.
Actively involved in researching how new treatments such as Avastin
can be integrated into cancer care, Dr Perren a regular contributor to
the academic literature.
Conditions treated by Dr Timothy Perren
Dr Perren offers treatment for breast cancer and the whole range of cancers affecting the female reproductive system, including:
- Ductal and lobular breast cancer
- Inflammatory breast cancer
- Paget's disease
- Male breast cancer
- Ovarian cancer
- Primary peritoneal cancer
- Endometrial cancer
- Cervical cancer
- Vulval cancer
- Mixed mullerian tumour and other rare gynaecological cancers
Targeted therapies for breast and gynaecological cancers
Targeted or biological therapies are drugs that change the way that cells interact or communicate with each other. There are three different types:
These are laboratory created antibodies that are designed to recognise the protein on the surface of a cancer cell and lock onto it, stopping the cell from growing and destroying it. They can also be used to directly deliver a cancer drug or radioactive substance to a cancer cell or to stimulate the body's immune system into destroying cancer cells. Examples of monoclonal antibodies are Avastin (Bevacizumab), used to treat metastatic breast cancer, advanced ovarian cancer, fallopian tube cancer and peritoneal cancer, and Herceptin (Trastuzumab) used in the treatment of early and metastatic breast cancer.
Cancer growth inhibitors
Cancer growth inhibitors interfere with the chemical communication process that cancer cells use to grow and divide. Tyverb (Lapatinib) is a cancer growth inhibitor used to treat women and men with advanced or metastatic breast cancer.
These drugs interfere with the development of blood vessels in a tumour, depriving it of the oxygen and nutrients it needs to survive. As well as being a monoclonal antibody, Avastin is also an angiogenesis inhibitor.
Accreditation and admitting rights at private hospitals
Mr. Timothy Perren is an accredited consultant for the UK's leading private healthcare providers and private hospitals including Spire Healthcare.
Intuition Communication Ltd bears no responsibility for information published on this website, which concerns or relates to advertisers and their products and services. Read Disclaimer in full.